Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Target Price at $70.22

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has earned an average rating of "Moderate Buy" from the nine analysts that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $70.22.

A number of research analysts have weighed in on the stock. Cantor Fitzgerald reissued a "neutral" rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Royal Bank of Canada restated an "outperform" rating and set a $64.00 target price on shares of Acadia Healthcare in a research note on Friday, January 10th. TD Cowen dropped their price target on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a research report on Tuesday, January 7th. KeyCorp raised Acadia Healthcare from a "sector weight" rating to an "overweight" rating and set a $70.00 price objective for the company in a research report on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "hold" rating to a "buy" rating and upped their target price for the company from $45.00 to $75.00 in a research note on Thursday, December 12th.

Institutional Trading of Acadia Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Acadia Healthcare by 22.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company's stock worth $12,439,000 after buying an additional 56,647 shares during the period. Voloridge Investment Management LLC acquired a new position in shares of Acadia Healthcare in the 4th quarter valued at $15,770,000. Squarepoint Ops LLC bought a new position in shares of Acadia Healthcare in the 4th quarter worth $1,087,000. Two Sigma Investments LP acquired a new stake in shares of Acadia Healthcare during the fourth quarter worth $7,648,000. Finally, State of Wyoming acquired a new position in Acadia Healthcare in the fourth quarter valued at about $56,000.

Acadia Healthcare Stock Performance

Shares of NASDAQ:ACHC traded up $0.73 during trading on Friday, reaching $41.79. The stock had a trading volume of 140,970 shares, compared to its average volume of 1,420,337. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a fifty day simple moving average of $42.09 and a two-hundred day simple moving average of $53.67. The firm has a market capitalization of $3.88 billion, a price-to-earnings ratio of 13.71, a P/E/G ratio of 1.75 and a beta of 1.30. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.